Document is current
Any future updates will be listed below
-
Authors
Crescioli, Giada https://orcid.org/0000-0002-1071-6120
Lombardi, Niccolò https://orcid.org/0000-0002-9666-0438
Arzenton, Elena https://orcid.org/0000-0002-9778-1522
Luxi, Nicoletta https://orcid.org/0009-0009-2615-0756
Fumagalli, Stefano https://orcid.org/0000-0002-6950-3875
Bonaiuti, Roberto https://orcid.org/0000-0001-9644-499X
Cacini, Costanza https://orcid.org/0009-0008-3231-5273
Mannaioni, Guido https://orcid.org/0000-0002-8273-7377
Trifirò, Gianluca https://orcid.org/0000-0003-1147-7296
Moretti, Ugo https://orcid.org/0000-0001-5108-5807
Vannacci, Alfredo https://orcid.org/0000-0001-5259-2026
-
Funding
Funding for this research was provided by:
Università degli Studi di Firenze
- License Information
-
More Information
Article History
Received: 27 January 2025
Accepted: 23 March 2025
First Online: 7 April 2025
Declarations
:
: This article does not contain any study with humans and animals performed by any of the authors.
: Due to the retrospective nature of the present study and data anonymization, patient’s consent to participate was not required.
: VigiBase, the WHO global database of ICSRs is the source of our information. The information comes from a variety of sources, and the probability that the suspected adverse event is drug-related is not the same in all cases; the information does not represent the opinion of the UMC or WHO.
: Over the last 3 years, Professor Gianluca Trifirò has participated in advisory boards and seminars funded by Sanofi, MSD, Eli Lilly, Sobi, Celgene, Daichii Sankyo, Novo Nordisk, Gilead, and Amgen. He is the scientific coordinator of the academic spin-off “INSPIRE srl”, which has received funding from several pharmaceutical companies (i.e., PTC Pharmaceuticals, Kiowa Kirin, Shonogi, Shire, Novo Nordisk, and Daichii Sankyo) for conducting observational studies. Additionally, he is currently a consultant for Viatris in a legal case concerning an adverse reaction to sertraline. None of these listed activities are related to the topic of the article. All other authors have no conflicts of interest to disclose.
